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Abstract 
 This systematic review aimed to answer the clinical question, which perioperative 
enhanced recovery after surgery (ERAS) techniques are most effective in decreasing 
recovery time and length of stay for adults, aged 18-65, undergoing cholecystectomy 
surgery? In an effort to curb healthcare spending, ERAS is one way to reduce hospital-
associated costs. Originally developed in Denmark, ERAS is a patient-centered initiative 
that aims to reduce the body’s stress response, leading to improved patient outcomes and 
decreased hospital lengths of stay. Betty Neuman’s Systems Model was used as a 
theoretical framework to enrich the understanding of enhanced recovery and how it 
works to improve patient care.  
 This review followed the Preferred Reporting Items of Systematic reviews and 
Meta-Analyses (PRISMA) checklist. Using the PRISMA guidelines, current literature 
was systematically searched to select randomized controlled trials in a consistent, 
repeatable way. Data from the studies were collected, analyzed, evaluated, and reported 
in the same manner, using charts to organize data clearly. The following search terms 
were entered into the Cochrane database, the Cumulative Index of Nursing and Allied 
Health Literature (CINAHL), CINAHL Plus with Full Text, PubMed, PubMed Health, 
and MEDLINE: “ERAS,” “enhanced recovery,” “fast-track surgery,” “fast-track 
rehabilitation,” and “cholecystectomy.”  
 Four randomized-controlled trials met inclusion and exclusion criteria. The 
findings of the cross-study analysis determined that utilizing TIVA (with propofol and 
remifentanil) and/or including a 20% mannitol infusion pre-induction are two ERAS 
techniques that may lead to improved recovery times and shorter lengths of stay for 
patients undergoing laparoscopic cholecystectomy surgeries.  
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SYSTEMATIC REVIEW: ENHANCED RECOVERY AFTER CHOLECYSTECTOMY 
SURGERY 
Background/Statement of the Problem 
In order to understand the importance of enhanced recovery, one first needs to 
look at the health care system as a whole. Healthcare costs are a major issue in today’s 
economy. With an aging population and less-than-efficient medical practices, these costs 
only continue to rise. The centers for Medicare and Medicaid Services reported an 
increase of 5.8% in national health expenditure in 2015, now accounting for 17.8% of 
gross domestic product. Increased spending is expected each year through 2025 at an 
average rate of 5.6% per year. In 2015, hospital care accounted for 38.3% of health 
spending and the working-age group was responsible for 54% of the overall expenditure, 
though they made up 61% of the population (NHE Fact Sheet, 2017). Complications 
related to surgery, long ICU stays, long overall hospital visits, as well as many other 
factors all contribute to these high healthcare costs.  
  There are many potential ways to lower spending and cut back healthcare costs. 
As stated above, hospital costs make up almost 40% of health spending, the most of any 
category, making this is a natural place to start looking for solutions. Some suggestions 
include methods to rapidly identify and treat infections (Perez et al., 2013), incorporating 
newer, more cost-efficient procedures, eliminating wasteful practices, decreasing length 
of stay and using standardized methods and best practices to improve outcomes and their 
implementations (Sahni, Chigurupati, Kocher, & Cutler 2017). While not all of these 
methods are necessarily appropriate or timely ways to decrease costs, there are a few that 
do not require additional resources. Providing standardized, yet patient-specific care can 
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lead to faster recovery times and decreased lengths of stay, therefore decreasing overall 
costs. The need for this kind of patient-centered care is what led to the development of 
enhanced recovery after surgery programs. 
 Enhanced recovery after surgery, or ERAS, is an initiative that aims to improve 
patient outcomes, and decrease hospital lengths of stay by decreasing the body’s stress 
response (Enhanced Recovery Partnership Programme, 2010). It was originally 
developed in Denmark and has now spread through most parts of Europe and the 
Americas. Various elements of the program include the following: 
• pre-admission counseling, 
• no bowel prep, 
• fluid and carbohydrate loading, 
• no fasting, no premedication, 
• no nasogastric tubes, 
• mid-thoracic epidural anesthesia/analgesia, 
• short-acting anesthetic agents,  
• avoidance of sodium and fluid overload,  
• short incisions, no drains,  
• warm air body heating in the operating room,  
• routine mobilization care pathway,  
• non-opiate oral analgesics/NSAIDs,  
• prevention of nausea and vomiting,  
• stimulation of gut motility,  
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• early removal of catheters,  
• perioperative oral nutrition, and  
• auditing of compliance/outcomes (Fearon et al., 2005).  
While these elements are at least somewhat evidence-based, not all of the evidence is 
thorough or even consistent. Cholecystectomies are a common same day general surgery, 
so they are a good model surgery to use in order to study various enhanced recovery 
implementations. For that reason, the purpose of this major paper is to complete a 
systematic review of current literature, in order to answer the clinical question, which 
perioperative ERAS techniques are most effective in decreasing recovery time and length 
of stay for adults, aged 18-65, undergoing cholecystectomy surgery?  
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Theoretical Framework 
Using nursing theory to help guide and shape a research study contributes to the 
depth and meaning of the work. In this study, Betty Neuman’s Systems Model is used to 
guide the understanding of enhanced recovery after surgery as well as to help develop 
best practices from the aggregated studies. In the following section, a review and brief 
evaluation of this model will be conducted, followed by a discussion on implications to 
both anesthesia as well as evidence-based practice. 
Neuman’s model started out as a guide used to teach her students how to treat a 
patient as a whole when providing nursing care (Neuman & Fawcett, 2002). The model 
was meant to be a guide for understanding the parts of man and how to influence them. 
Her first published version was in 1972, though the diagram itself was copyrighted in 
1970. Her theory has been continuously studied, critiqued, and refined for almost 50 
years (Neuman & Fawcett, 2002).  
The Neuman Systems model is rooted in systems theory, which aims to 
systematically organize complex elements that interact with each other (Neuman & 
Fawcett, 2002). Since nursing is a large and complex field that continues to grow, a 
systematic approach for organizing nursing concepts is not only appropriate, but also 
quite useful. Neuman describes her model as, “… an open systems model that views 
nursing as being primarily concerned with defining appropriate action[s] in stress-related 
situations or in possible reactions of the client/client system” (Neuman & Fawcett, 2002, 
p.12). She also wrote that in this model, “the client is viewed as a composite of 
interacting variables- physiological, psychological, developmental, sociocultural, and 
spiritual- that are, ideally, functioning harmoniously or are stable in relation to both 
 
 
5 
internal and external environmental stressor influences” (p. 31). This statement shows 
that the client’s wellness must be assessed on multiple variables and also points to several 
other assumptions of the theory. Summaries of the model’s assumptions are described 
below, in Box 1. These assumptions were consistent throughout the theory’s text and 
tools, contributing to the clarity of the model. 
The purpose of Neuman’s System Model is prescriptive- i.e. what interventions 
should be done to achieve prescribed goals (Polit & Beck, 2017). It is a grand theory, 
encompassing nearly every aspect of nursing in any given setting (Neuman & Fawcett, 
2002). It has transferability to many other healthcare disciplines as well, making it quite 
broad in scope. Even though it is a grand theory with many concepts, the model defines 
them clearly as shown in Table A-1, found at the end of this review. Neuman’s original 
diagram helps further illustrate definitions and how components are connected within the 
theory. In the full publication, this diagram, along with many others, aid to further clarify 
the conceptual definitions (Neuman & Fawcett, 2002). These concepts are not 
operationally defined, however, as defining them in this way would narrow the 
applicability of this theory. Additionally, because the model is systematic in nature, the 
organization of concepts is logical, though the breadth of the model can sometimes make 
them hard to follow. These concepts are consistent throughout the explanation of the 
model though, providing a solid foundation for understanding. Theory analysis suggests 
this theory has thoroughly defined concepts and components, it is consistent in its use of 
definitions, and it is described in a logical way. In addition to analyzing Betty Neuman’s 
theory, it is also important to evaluate it. 
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Box 1. Neuman Systems Model: Assumptive Statements 
• “Each individual client or group as a client system is unique; each system is a 
composite of common known factors or innate characteristics within a normal, 
given range of response contained within a basic structure.” 
• “The client as a system is in dynamic, constant energy exchange with the 
environment.” 
• “Many known, unknown, and universal environmental stressors exist. Each differs 
in its potential for disturbing a client’s usual stability level, or normal line of 
defense. The particular interrelationships of client variables- physiological, 
psychological, sociocultural, developmental, and spiritual- at any point in time can 
affect the degree to which a client is protected by the flexible line of defense against 
possible reaction to a single stressor or combination of stressors.” 
• “Each individual client/client system has evolved a normal range of response to the 
environment that is referred to as the normal line of defense, or usual 
wellness/stability state. It represents change over time through coping with diverse 
stress encounters. The normal line of defense can be used as a standard from which 
to measure health deviation.” 
• “When the cushioning, accordianlike effect of the flexible line of defense is no 
longer capable of protecting the client/client system against an environmental 
stressor, the stressor breaks through the normal line of defense. The 
interrelationships of variables- physiological, psychological, sociocultural, 
developmental, and spiritual- determine the nature and degree of system reaction or 
possible reaction to the stressor.” 
• “The client, whether in a state of wellness or illness, is a dynamic composite of the 
interrelationships of variables- physiological, psychological, sociocultural, 
developmental, and spiritual. Wellness is on a continuum of available energy to 
support the system in an optimal state of system stability.” 
• “Implicit within each client system are internal resistance factors known as lines of 
resistance, which function to stabilize and return the client to the usual wellness 
state (normal line of defense) or possibly to a higher level of stability following an 
environmental stressor reaction.” 
• “Primary prevention relates to general knowledge that is applied in client 
assessment and intervention in identification and reduction or mitigation of possible 
or actual risk factors associated with environmental stressors to prevent possible 
reaction. The goal of health promotion is included in primary prevention.” 
• “Secondary prevention relates to symptomatology following a reaction to stressors, 
appropriate ranking of intervention priorities, and treatment to reduce their noxious 
effects.” 
• “Tertiary prevention relates to the adjustive processes taking place as reconstitution 
begins and maintenance factors move the client back in a circular manner toward 
primary prevention.” 
 
(Neuman & Fawcett, 2002, p. 14) 
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Components of theory evaluation include determining simplicity and clarity, 
usefulness, testability, generalizability, and significance (McEwen & Wills, 2014). This 
model is both very broad, as well as complex, so it is not considered to have parsimony. 
However, it is clear and detailed in its definitions. As a grand theory that has been 
developed for nearly 50 years, there are many uses that have been studied as well. The 
published model also provides systematic reviews of its use in various settings including 
clinical practice, nursing research, nursing education, and nursing administration, with 
several reviews and tools discussed under each section (Neuman & Fawcett, 2002). Many 
articles have used the Neuman System Model to determine best practices in different 
nursing fields, making it very useful for determining and implementing evidence-based 
practice, or EBP (Neuman & Fawcett, 2002). Because it takes into account the whole 
patient in a systematic way, this model lends itself well for use in developing EBP 
guidelines. In the recent few editions of the published model, assessment and intervention 
tools were published to aid in using this theory in practice. By doing so, the theory is 
more testable empirically and real-world applications can be seen more easily. As this 
theory is a broad systems theory, it is applicable to most other healthcare fields. The 
Neuman Systems Model has been used in fields such as medicine, physical and 
occupational therapies, education, psychology, and oncology, just to name a few 
(Neuman & Fawcett, 2002). Even specific tools for different fields have been developed 
from this theory, making it very generalizable. Finally, as this theory is useful, broad, 
well-tested and studied, it has a great deal of clinical significance, particularly to the field 
of nursing. It is not only relevant here in the United States, but is broad enough to 
encompass geographical, sociological, and cultural differences as well.  
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The Neuman Systems Model is not only applicable to research and nursing in 
general, but more specifically to the research and practice of nurse anesthesia. Martin 
(1996) shows how the practice of anesthesia could incorporate the Neuman Systems 
Model. The author suggests that as the CRNA is providing peri-operative anesthesia care, 
they are actually supporting the normal line of defense of the client as well. By impeding 
the stressors the client may experience, nurse anesthetists are using multi-level prevention 
techniques to help the patient achieve and maintain a homeostatic balance (Martin, 1996).  
Ume-Nwagbo, DeWan, and Lowry (2006) provide two case examples to illustrate the use 
of the model as a theoretical framework for determining best practices. They used the 
model to assess individual and family needs, as well as to develop a plan to deliver care 
in a respectful and knowledgeable way, honoring the client system. The model was a 
great choice for this work because it allowed the researchers to understand the whole 
client in regards to all five client variables, and to understand that each client will respond 
differently. This allowed the researchers to anticipate and prevent client responses to 
stressors with different levels of prevention (Ume-Nwagbo, DeWan, & Lowry, 2006). 
These articles demonstrate how Neuman’s System Model can be used in different settings 
and for different purposes, but always to support the client and assist in lessening the 
response to environmental stressors. 
Betty Neuman’s Systems Model is well-studied theory that helps organize and 
explain many aspects of nursing. In its breadth, this model will do two things to assist in 
the understanding and organization of this review. First, it will give deeper meaning to 
the techniques used in ERAS protocols, as they are standardized, yet patient-specific. 
These protocols were developed specifically to reduce the stress-response experienced by 
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the patient due to the surgery they received (Enhanced Recovery Partnership Programme, 
2010). The Neuman Systems Model looks at what environmental stressors are affecting 
the client as a whole, and determines which interventions are appropriate to reduce their 
specific stress-related response (Neuman & Fawcett, 2002). This leads to the second use 
for this review- the model lends itself well to developing evidence-based practice. The 
tools included as well as the concepts themselves, force the evaluator to look at every 
aspect of the patient and determine holistically, which interventions are most appropriate 
to reduce their stress response by strengthening patients lines of resistance and defense. 
For this review, the Neuman Systems Model is used as a guiding theoretical framework 
to provide deeper meaning and understanding of ERAS protocols, their implementations, 
as well as their outcomes in adults undergoing cholecystectomy surgery. The following 
literature review will further define the concepts of physiologic stress, the surgical stress 
response, and how ERAS can play a role in mitigating those responses. 
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Literature Review  
Cochrane, CINAHL Plus, Pubmed, and Medline databases were searched. Search 
terms were applied both independently and in combination, which included: physiologic 
stress, surgical stress, stress response, enhanced recovery, ERAS, and fast-track surgery. 
Studies published between 2000-2018 were included in the search. Additionally, seminal 
works that were published as early as the 1950s were included, as they are vital to our 
current understanding of the surgical stress response. The following literature review 
summarizes what the stress response is, how that differs from the surgical stress response, 
and what current ERAS literature recommends is the best way to attenuate those 
responses in order to recover a patient efficiently. 
Stress and the body 
 Stress comes in many different forms and from a variety of causes. As early as 
1970, Clarke determined that the magnitude of a stressor affects the response. In his 
study, Clarke compared serum glucose levels in patients under different anesthetic 
techniques for a variety of procedures and found that the rises in stress-induced blood 
glucose levels were proportional to the amount of stimulus implemented. Smaller stimuli 
led to smaller increases in blood glucose, when compared to larger stimuli. The term 
‘stress’ tends to have a negative connotation, but there is also good stress, or eustress, that 
results in a positive stress response. Additionally, many other variables influence how 
and to what degree a stress response is elicited (Greenberg, Carr, & Summers, 2002). 
Neuman describes stressors as “environmental factors that are intra-, inter-, and 
extrapersonal in nature and have the potential for disrupting system stability by 
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penetrating the system lines of defense and resistance. Their outcome may be either 
positive or negative” (Neuman & Fawcett, 2002, pg. 322-324). In other words, a stressor 
is a true or perceived threat to a person’s homeostatic balance. Stressors can come from 
all kinds of sources, including physiological, psychological, sociocultural, 
developmental, and even spiritual sources (Neuman & Fawcett, 2002). The following 
section will discuss the stress response, with a focus on the biological, or physiological, 
components. 
The Stress Response. Over the years of stress-related research, several 
components have emerged as mechanisms involved in the stress response. Cuthbertson 
(1932) demonstrated that after a stressful stimulus, in this case limb injury, the body 
showed manifestations of increased catabolism. Temperature in all case studies published 
rose one to two degrees Celsius within the first 48 hours of injury and lasted for one to 
two days. Additionally, by graphically displaying the collected data, Cuthbertson was 
able to determine that oxygen consumption increased in the days following injury, and in 
a similar fashion, nitrogen excretion increased as well (Cuthbertson, 1932). Together, 
these changes are indicative of increased catabolism. Further observations by Selye 
(1956) illustrated that the body’s reaction to stress is an adaptive response that allows the 
individual to compensate for the disruption in homeostasis. Two components in particular 
make the response adaptive. The first component is that the body mobilizes energy, i.e. 
catabolism.  The second is that “a new pattern of energy distribution emerges” 
(Schneiderman, Ironson, & Siegel, 2005, pg. 5). Energy is redistributed to the tissues that 
become more active upon initiation of the stress response. Skeletal muscles and the brain 
receive increased amounts of the newly mobilized energy to support a “fight or flight” 
 
 
12 
stress response. In an acute stress response, the immune system also activates and 
mobilizes cells, readying the body to respond to a biological or physical invasion 
(Schneiderman et al., 2005). While these short term effects are intended to aid the body in 
battling an acutely stressful situation, if the threat persists or is extremely severe, the 
continued stress response can have deleterious effects on the body that can ultimately 
damage health, especially in those that are more vulnerable (i.e. children, older adults, & 
individuals with many co-morbidities) (Schneiderman et al., 2005). 
 The Stress System. Tsigos, Kyrou, Kassi, and Chrousos (2016) comprehensively 
discuss the stress response and help to define ‘the stress system’. These authors point out 
that although the entire central nervous system (CNS) is involved to some degree in the 
maintenance of homeostasis, certain areas of the brain have key roles in the stress 
response. The main components can be found in the hypothalamus and brain stem. They 
include, but are not limited to, the parvocellular corticotropin-releasing hormone (CRH) 
as well as arginine-vasopressin (AVP) neurons, found within the hypothalamus, the CRH 
neurons in the medulla, as well as the locus coeruleus (LC), norepinephrine (NE)-
synthesizing cells, and other catecholaminergic cell groups of the medulla and pons.  
These components, along with their peripheral counterparts, make up the hypothalamic-
pituitary-adrenal (HPA) axis, a crucial component in the stress system. A separate circuit, 
consisting of stimulatory and inhibitory networks as well as multiple sites for peripheral 
interactions, forms a physiologic system within the CNS that leads to activation of the 
stress system. The activating circuit stimulates both the sympathetic nervous system 
(SNS) as well as the HPA axis, and it is the interactions between these components that 
allow the body to modulate the adaptive stress response (Tsigos et al., 2016).  
 
 
13 
Hypothalamic-pituitary-adrenal axis. In order to fully understand how CRH, 
AVP, and other necessary components lead to the adaptive response to stress, one needs 
to understand how the HPA axis works. The integrity and regulation of the HPA axis is 
crucial to the stress response. CRH is the primary regulator of adrenocorticotropic 
hormone (ACTH) secretion by the anterior pituitary, with AVP acting as a potent 
synergistic factor (Tsigos et al., 2016). After secretion by the anterior pituitary, ACTH 
travels to its target organ, the adrenal glands. ACTH is a critical regulator of 
glucocorticoids (i.e. cortisol) and adrenal androgen secretion and may also help regulate 
aldosterone. Glucocorticoids are the final effectors of the HPA axis. They act on 
intracellular receptors found throughout the entire body and can produce a wide range of 
effects. Actions of glucocorticoids include trans-activating or trans-repressing appropriate 
hormone-response genes, altering the electrical potential of neurons, regulating 
mitochondrial functions and energy metabolism, influencing the secretion rates of certain 
proteins, as well as regulating the HPA axis and terminating the stress response (Tsigos et 
al., 2016).  
 Sympathetic nervous system. In addition to HPA axis involvement, the 
sympathetic nervous system also plays a large role in the stress response. The SNS, along 
with the parasympathetic nervous system (PNS) are branches of the autonomic nervous 
system (ANS). The SNS provides a rapid mechanism to control the response to stress, 
also known as the flight or fight response (Tsigos et al., 2016). The SNS and PNS often 
work hand in hand to stimulate or suppress various functions of the body. Innervation of 
peripheral organs is via bilateral chains of sympathetic ganglia that synapse with neurons 
that innervate smooth muscle of the vasculature, skeletal muscles, the heart, kidneys, gut, 
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adipose tissue, and many other organs/tissues. Additionally, sympathetic impulses can act 
on the adrenal medulla, leading to the secretion of epinephrine and norepinephrine as 
well. These actions culminate and lead to increased blood pressure, contractility and heart 
rate, and it also prepares the body to act quickly, whether it be to fight or run (Tsigos et 
al., 2016).  
The surgical stress response 
 Not only does the body experience threats to homeostasis, it also has specific 
responses to surgical procedures. According to Betty Neuman, surgery would certainly be 
classified as a stressor, as it disrupts the stability and homeostasis of multiple systems 
(Neuman & Fawcett, 2002). The surgical stress response has been studied since the early 
1900s, as well as ways to mitigate the effects of the stress response during and after 
surgery.  
Historical discoveries. Cannon (1915) was one of the first scientists studying 
stress to write a research text about it. The text contained research summaries from the 
previous 40 years, as well as his own empirical evidence evaluating the body’s response 
to pain, hunger, fear, and rage. One experiment Cannon conducted involved placement of 
a tube in the throat of animals without anesthesia. The intense physical pain these animals 
experienced was associated with elevated urine glucose values. Testing urine for stress-
related chemicals was a commonly used method to determine the human response to 
surgery. It wasn’t until decades later, when Hine et al. (1976) determined that plasma 
concentrations of catecholamines (adrenaline and noradrenaline) provided a more 
accurate reflection of the stress response. His research appraised catecholamine 
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concentrations before, during, and after cardiopulmonary bypass. He found that plasma 
concentrations of both adrenaline and noradrenaline increased with bypass, averaging 
0.42 mcg/L adrenaline and 0.28 mcg/L noradrenaline before bypass, increasing to 0.94 
mcg/L adrenaline and 0.78 mcg/L noradrenaline during bypass, and then backing off to 
0.67 mcg/L adrenaline and 0.58 mcg/L noradrenaline after completion of bypass (Hine et 
al., 1976). Previous bypass data showed little to no change in catecholamine levels during 
bypass when measured using urinalysis, showing that alternative methods of analysis, 
such as assessing plasma concentrations, were therefore needed to determine the 
significance of stress on the body during surgery (Hine et al., 1976). By applying these 
findings, Pickar, Cohen and Dubois (1983) found that plasma levels of beta-endorphin as 
well as cortisol were significantly increased after abdominal surgery. (p = 0.01). 
Moreover, they determined that there was an inverse relationship between plasma levels 
of these substances and the amount of analgesia, in this case morphine, required post-
operatively (p = 0.01).  
Elevated levels of cortisol and endorphins are not the only way to determine the 
existence of a stress response. Gaubatz and Wehner (1991) focused their research on the 
physiological changes associated with stress and how to attenuate them. In this study, 
doses of esmolol, fentanyl, or a combination of both were used to blunt the adrenergic 
physiological response to laryngoscopy during induction of anesthesia in 44 patients. 
Patients were randomly divided into four groups to receive one of the following: esmolol 
1mg/kg with fentanyl 2mcg/kg, esmolol 1 mg/kg alone, fentanyl 3.5 mcg/kg alone, or 
placebo (control). The results showed that the patients treated with fentanyl were 
significantly less responsive to the effects of intubation than those not receiving fentanyl 
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(p < 0.001) in terms of SBP, DBP, and MAP. Additionally, heart rate increases were less 
when esmolol was used (p < 0.05) Therefore, the stress response was attenuated the most 
in patients who received doses of both medications (Gaubatz & Wehner, 1991). The 
research from the past century demonstrates that there is in fact a stress response to 
surgery, there are supported methods to attenuate that response, and the methods for 
doing so are continuously changing.  
Desborough (2000) conducted a thorough review of surgical stress to date. He 
found that the surgical stress response is not largely different from the generic stress 
response, as it too activates the sympathetic nervous system and is characterized by an 
increase in pituitary hormone secretion. The SNS is activated by the hypothalamus during 
the surgical stress response. SNS activation leads to an increase in catecholamine 
secretion from the adrenal medulla (adrenergic response), namely norepinephrine and 
epinephrine (Desborough, 2000). Additionally, surgical stress is so significant that it can 
cause a mass discharge of catecholamines when large portions of the SNS are all 
discharge simultaneously, increasing the body’s ability to participate in the fight or flight 
response.  
 Endocrine activation is also stimulated by the hypothalamus via releasing factors. 
The anterior pituitary synthesizes and releases increased amounts of ACTH, growth 
hormone (GH), and prolactin (PRL) in response to a surgical stimulus (Desborough, 
2000). While the levels of ACTH, GH, and PRL increase, levels of other anterior 
pituitary hormones, including thyroid-stimulating hormone (TSH), follicle-stimulating 
hormone (FSH), and luteinizing hormone (LH) remain relatively stable upon surgical 
stimulation. The posterior pituitary produces increased arginine vasopressin which acts as 
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an anti-diuretic hormone as well as synergistically stimulating the release of ACTH from 
the anterior pituitary (Desborough, 2000).  
Triggering the surgical stress response.  
 Egdahl (1959) studied trauma in both the innervated and denervated extremities 
of dogs to determine if a “wound hormone” existed, triggering a stress response. While 
he did not find enough evidence to support his claim at the time, his research helped lead 
to the discovery of cytokines. It is believed that cytokines are a key activator involved in 
this process. According to Desborough (2000), an early response to tissue injury involves 
activated immune cells, including leukocytes and fibroblasts, producing cytokines in 
order to mediate the immune and inflammatory responses. Hall’s medical text now 
describes cytokines as small proteins that act like hormones as part of the immune 
system’s response to insult or injury (Hall & Guyton, 2016). 
The acute phase response. The acute phase response involves the changes that 
occur in the body in response to tissue injury. It initiates the stress response by 
stimulating the hypothalamus via an afferent sensory signal from the site of injury, or 
surgery (Desborough, 2000). Surgery causes the release of specific cytokines: 
interleukin-1 (IL-1), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). IL-1 and 
TNF-α are released immediately upon tissue damage and they stimulate the production of 
IL-6, which is the main cytokine responsible for the acute phase response according to 
Desborough (2000).  
Another major component of the acute phase response involves the liver. The 
liver decreases its production of some proteins, such as albumin and transferrin, in order 
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to produce acute phase proteins, including C-reactive protein (CRP), fibrinogen, and α2-
macroglobulin  (Desborough, 2000). These proteins act as inflammatory mediators, 
scavengers in tissue repair, and they are responsible for the changes that occur to produce 
IL-6. IL-1 and IL-6 can both stimulate the pituitary to release higher levels of ACTH, 
stimulating or potentiating the stress response. In studies that compared the stress 
response in laparoscopic surgery versus open surgery, the stress response was not greatly 
reduced due to lesser surgical trauma, in spite of finding the concentrations of injury-
related proteins to be lower in laparoscopic procedures. It is suggested therefore, that 
stimuli for the stress response arise from a combination of afferent nerve fibers from 
visceral and peritoneal sources, as well as from the abdominal wall itself (Desborough, 
2000). To further support this, Jurczok, Zacharias, Wagner, Hamza & Paolo (2007) 
studied the systemic response in laparosopic versus open radical prostatectomy. They 
found an increase in IL-6 and CRP postoperatively in both types of surgery, but there was 
no significant difference in serum levels between the two.  
Implications for intra-operative anesthesia management.  
 The surgical stress response has implications for the intra-operative period, 
particularly for the anesthesia provider. First, it is important for the provider to 
understand the stress response, in order to anticipate, prevent and mitigate those changes 
as much as possible during surgery. Various pharmacological agents have been studied to 
determine their role in reducing the stress response. The following table summarizes the 
effects of opioids, propofol, etomidate, benzodiazepines, clonidine, and regional 
anesthesia techniques on the surgical stress response. 
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Table 1. Effects of pharmacological agents 
 
Pharmacologic 
agent 
Effect on stress response 
Opioids Suppresses HPA axis in humans at the hypothalamic level 
Morphine: suppresses release of corticotropin, leading to 
lower levels of cortisol; blocks secretion of GH 
Propofol Induction dose will suppress circulating cortisol, though it 
does not prevent secretion; deep or prolonged anesthesia doses 
will completely eliminate circulating cortisol 
Etomidate Interferes with steroid production by inhibiting the enzymes 
responsible; blocks production of aldosterone and cortisol for 
6-12 hours after a single induction dose 
Benzodiazepines Lessens the cortisol responses to surgery in the abdomen and 
periphery; site of action is at the hypothalamic-pituitary level 
Clonidine Centrally-acting anti-hypertensive (α2-agonist); produces 
sympatholytic activity, leading to improved hemodynamic 
stability; also lessens anesthesia and analgesia requirements 
Regional anesthesia Epidurals with extensive use of local anesthetics will prevent 
the endocrine and metabolic responses to surgeries in the 
pelvis and lower limbs; blocks afferent input to the 
hypothalamus and efferent output to the autonomic neural 
pathway, preventing adrenocortical and glycemic responses to 
surgical stress  
(Desborough, 2000, pgs 113-115; Paola et al., 2015) 
 Post-operative clinical consequences.  
 The culmination of the surgical stress response has an array of postoperative 
clinical consequences on the body. Cuthbertson (1932) observed that there is a 2-phase 
metabolic response that involves an initial “ebb” phase, followed by a “flow” phase after. 
The initial ebb phase begins a few hours after surgery and persists for 48-72 hours, 
wherein metabolic activity is decreased. The flow phase starts after the ebb phase and 
lasts for days to weeks, depending on the injury type and severity and is a period of 
increased metabolic activity (Cuthbertson, 1932). Researchers have since studied these 
responses in further detail. Moore (1953) confirmed a state of decreased metabolism 
following surgery in his observational studies of the surgical stress response. He found 
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that the body was excreting higher levels of nitrogen, potassium, body fat, and water the 
first three to four days postoperatively, as they were not being used metabolically. In the 
days after that (post-operative days five to eight), Moore found that there were decreased 
amounts of potassium and nitrogen excreted, and increased amounts of sodium, 
suggesting the body is increasing its metabolic functioning during that time (Moore, 
1953).  
 Studies since the 1950s continue to confirm these findings. In the last decade, 
researchers have been able to determine other physiological differences associated with 
post-operative changes in the body. Finnerty, Mabvuure, Ali, Kozar, and Herndon (2013) 
determined physiological responses in the first phase to include reduced cardiac output, 
reduced oxygen consumption, reduced basal metabolic rate, and reduced glucose 
tolerance (Finnerty et al., 2013). Phase II responses include increased cardiac output, 
increased respiratory rate, increased oxygen consumption, hyperglycemia, 
hypermetabolism, increased skeletal muscle breakdown, and a negative nitrogen balance 
(Finnerty et al., 2013). The hypermetabolism response is partially due to increased levels 
of catecholamines and affects carbohydrates, proteins, and fats. With the addition of the 
heightened inflammatory response, these changes can lead to organ failure. To lessen 
these responses, nutritional and pharmacological interventions have been studied to 
determine the most effective ways to improve patient outcomes. Due to the different 
phases involved in the response, dynamic interventions are needed to meet the patient’s 
varying metabolic needs.  
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Enhanced Recovery After Surgery  
Enhanced recovery after surgery, or ERAS, is an initiative that aims to improve 
patient outcomes, and decrease hospital lengths of stay by decreasing the body’s stress 
response to surgery (Enhanced Recovery Partnership Programme, 2010). It was originally 
developed in Denmark and has now spread through most parts of Europe and the 
Americas. Different elements of the program include pre-admission counseling, no bowel 
prep, fluid and carbohydrate loading, no fasting, no premedication, no nasogastric tubes, 
mid-thoracic epidural anesthesia/analgesia, short-acting anesthetic agents, avoidance of 
sodium and fluid overload, short incisions, no drains, warm air body heating in the 
operating room, routine mobilization care pathway, non-opiate oral analgesics/NSAIDs, 
prevention of nausea and vomiting, stimulation of gut motility, early removal of 
catheters, perioperative oral nutrition, and auditing of compliance/outcomes (Fearon et 
al., 2005). While these elements are at least somewhat evidence-based, not all of the 
evidence is thorough or even consistent.  
Empirical Evidence in Support of ERAS protocols.  
There are many ERAS elements that have been well studied and implemented. 
Thus far, research has been conducted in several perioperative surgical areas including 
colorectal, gynecological, orthopedic, and cardiac.  In a randomized control trial, 
conducted by Abdikarim et al. (2015) authors aimed to evaluate the safety and efficacy of 
ERAS programs in patients undergoing laparoscopic radical gastrectomy for stomach 
carcinomas. Sixty-one participants were recruited and then randomly assigned into the 
two groups (Abdikarim et al., 2015). The ERAS group had 30 participants and the control 
group had 31, though neither group was blinded. Apart from the ERAS interventions, 
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which included no fasting, no bowel prep, no drainage or NG tubes, restricted IV fluids, 
and early mobilization, the two groups received the same surgical procedure (Abdikarim 
et al., 2015). The ERAS group showed statistically significant improvements over the 
control group on every measure. Average time to ambulation was 2.6 days compared to 
3.1 (p = 0.04); average time to defecation was 3.1 days compared to 3.6 (p = 0.01); 
average time to food intake was 2.9 days compared to 3.5 (p = 0.003); and length of stay 
was 6.8 days compared to 7.7 (p = 0.002). The sample size was small, mainly male (2:1 
ratio), and not necessarily racially diverse, making generalizability limited (Abdikarim et 
al., 2015). Overall, this study supported the use of ERAS protocols in laparoscopic 
radical gastrectomies as a safe and more effective alternative to traditional care.  
In a similar study by Liang et al. (2016), investigators compared a group who 
received the ERAS protocol versus a control group receiving standard care in 
laparoscopic hepatectomy procedures. The ERAS group received interventions such as 
pre-operative education, no bowel preparation, no fasting, carbohydrate loading prior to 
surgery, fewer abdominal drains, less IV fluids, addition of local anesthesia, thorough 
pain control, early advancement of diet and early mobilization. The sample included 187 
participants who were randomized and blinded into two groups. There were 80 
participants in the ERAS protocol and 107 in the control group. Pain scores were 
obtained using a visual analog scale, ranging from zero to ten. The results showed that 
pain scores were significantly lower in the ERAS group on postoperative day one (an 
average score of 1.9 versus 2.6, p = 0.001), day three (average score of 1.3 versus 2.4, p = 
0.001), and day five (average pain score of 0.8 versus 1.8, p = 0.001). The ERAS group 
also advanced their diet faster (1.7 days versus 4.5, p = 0.001); post-operative stays were 
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shorter (6.2 versus 9.9, p = <0.001); and overall hospital cost was less ($6871 versus 
$7948, p = 0.02) (Liang et al., 2016). This study provided no data on socio-economic 
status, and because the study took place at a single Chinese hospital, generalizability of 
the results over different races and socio-economic statuses is not possible. The 
significant results of this study demonstrated support of the use of ERAS protocols in 
laparoscopic hepatectomies (Liang et al., 2016).  
Moya et al. (2016) recognized a gap in knowledge regarding ERAS in their 
prospective multicenter randomized single-blind clinical trial. One element of the ERAS 
protocol recommends using an oral immunonutrient supplement to stimulate a better 
immune response in the patient, leading to fewer infections. There was little clinical 
support for the recommendation, so Moya et al. sought to strengthen the evidence by 
evaluating perioperative standard oral nutrition supplements versus immunonutrition in 
patients undergoing colorectal resection in an enhanced recovery pathway.  Two-hundred 
and forty-four participants were recruited and randomized into two groups (Moya et al., 
2016). Participants were asked to drink two 200ml cartons of their assigned supplement 
per day for seven days prior to the surgery, as well as for five days post-operatively. All 
participants received standardized elements of ERAS, including: iron supplementation, 
no colon preparation, goal-directed fluid management with esophageal doppler 
monitoring, avoidance of drains, no nasogastric tubes, early mobilization, opioid-free 
pain control, and prophylactic treatment for nausea and vomiting (Moya et al., 2016). 
Because this study compared two ERAS protocols with only the nutritional supplements 
changed, the research team was able to isolate the one element on the protocol they were 
interested in. Outcomes studied were complication rates, broken down into surgical 
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complications and infectious complications (Moya et al., 2016). The immunonutrient 
group had fewer overall complications- 23% compared to 35.2%, as well as fewer 
infectious complications- 10.7% compared to 23.8% in the traditional supplement group 
(Moya et al., 2016). These results support the use of nutritional supplements as part of an 
ERAS protocol. Overall, this study demonstrated that individual elements within an 
ERAS protocol are continuously being studied and updated to reflect the most evidence-
based recommendations. 
Empirical Evidence Refuting ERAS Protocols.  
While the literature suggests that ERAS protocols are successful as a whole, there 
are some bodies of work that suggest some of the elements may not be as useful as 
others. For example, Atkinson et al. (2016) conducted a clinical trial to compare 
postoperative chewing gum to standard care, in order to determine the effect of chewing 
gum on post-operative colorectal resection patients. Researchers recruited 412 patients 
from five UK hospitals, who were then randomized and into the two groups: chewing 
gum or control. Both patient groups received the same surgical procedures as well as 
perioperative care. After surgery, patients in the experimental group were asked to chew 
gum four times a day for at least ten minutes at a time, and the control group was asked to 
abstain from gum-chewing (Atkinson et al., 2016). The results showed no statistical 
difference between groups when looking at their primary outcome, length of stay, or 
secondary outcomes, such as time to first bowel sound, diet advancement, and first bowel 
movement (Atkinson, 2016). The authors suggested this result could be due to 
compliance issues within the two study groups, or that gum on its own is not as effective 
as pairing it with other ERAS elements.  
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ERAS Implementation.  
Discrepancies in the existent literature are not limited to supporting or refuting 
ERAS protocols. A study by Mawdsley, Baker, Desai, Green, & Jevons (2016) 
demonstrates a lack of consistency in the implementation of ERAS protocols. The 
investigators used a prospective region-wide service evaluation to determine what 
differences exist in the analgesia used in enhanced recovery pathways across the 
northeast of England. Ninety-one cases from 5 different hospitals were examined from 
pre-operative through post-operative care. All participants underwent either a total hip or 
knee replacement and agreed to participate in an enhanced recovery pathway. 
Researchers designed a proforma to assess what peri-operative ERAS interventions were 
used in each case (Mawdsley et al., 2016). Elements that were evaluated included: 
preoperative medications, the use of local anesthesia, general anesthesia, or spinal 
anesthesia as well as postoperative medications. Three of the five facilities used a 
complete enhanced recovery (ER) pathway, while the other two simply included a few 
elements of ERAS. For preoperative analgesia, 46% of patients received nothing, 46% 
received gabapentin, 19% received dexamethasone, 18% received lansoprazole, and 8% 
received oxycontin (Mawdsley et al., 2016). In the facilities that used an ER pathway, 
local anesthesia was used in 96% of the cases, 4% used general anesthesia, and 96% used 
spinal anesthesia. For the facilities that did not use a full ER pathway, only 5% of patients 
received pre-operative analgesia, 38% received local anesthesia, 20% received general 
anesthesia, and 78% received spinal anesthesia (Mawdsley et al., 2016). Postoperatively, 
only oral analgesia was given the ER pathway cases, while PCA analgesia was used in 
40% of the non-ER pathway surgeries. Each patient studied had a different analgesia 
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regimen perioperatively (Mawdsley et al., 2016). This wide variety of analgesia types and 
uses within an ERAS protocol points to the need to standardize analgesia and anesthesia 
plans for optimal implementation and effectiveness. This study was somewhat limited in 
its scope, as it had a small sample, and all were from one geographic location, however, it 
demonstrates the need for further standardization within the ERAS protocols.  
These studies demonstrate the available research about enhanced recovery 
programs as well as the usefulness and importance of integrating these pathways into 
hospitals and surgery centers. In particular, studies like Abdikarim et al. (2015) and Liang 
et al. (2016) support the use and effectiveness of ERAS protocols for hepatectomies and 
gastrectomies, both general surgeries. Within the ERAS protocols, some elements are 
hardly studied at all, warranting more thorough research in the area, like Moya et al. 
(2016) demonstrated. Other elements have no real evidence to support their use. Atkinson 
et al. (2016) showed chewing gum to have no effect on post-operative outcomes, despite 
previous studies supporting its use. Finally, Mawdsley et al. (2016) points out 
discrepancies in the implementation of ERAS, concluding there is no standardization in 
the execution of ERAS protocols. Overall, this literature displays a need for a more 
thorough review of techniques involved in ERAS programs to determine the most 
effective methods. 
In summary, the stress response, or more specifically, the surgical stress response, 
significantly alters a patient’s metabolism, hormone secretion, and nervous system 
activation. The stress response evolved as a way for humans to have enough energy to 
react to stressful situations, as a survival mechanism. During surgery, that response is not 
necessary, and often can be detrimental to a patient’s wellbeing and recovery 
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(Desborough, 2000). A large component to the practice of anesthesia involves attenuating 
the surgical stress response to keep the patient hemodynamically and otherwise stable, so 
surgery can be performed and only minimally interrupt the patient’s homeostasis. With 
the research and development that has gone into enhanced recovery programs, providers 
have an additional mechanism to combat the stress response and improve patient 
outcomes and decrease recovery time, leading to shorter hospital stays. The purpose of 
this major paper, therefore, is to complete a systematic review of literature, in order to 
answer the clinical question, “which perioperative ERAS techniques are most effective in 
decreasing recovery time and length of stay for adults, aged 18-65, undergoing 
cholecystectomy surgery?”    
 Next, the methods used for this systematic review will be discussed. 
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Methods 
Purpose  
 The purpose of this major paper was to complete a systematic review of relevant 
literature, in order to answer the clinical question, “which perioperative ERAS techniques 
are most effective in decreasing recovery time and length of stay for adults, aged 18-65, 
undergoing cholecystectomy surgery?”  
Design & Procedure 
 A systematic review of current empirical literature was the research design chosen 
to answer the above clinical question. This review followed the Preferred Reporting 
Items of Systematic reviews and Meta-Analyses (PRISMA) checklist, as seen in 
Appendix B.  PRISMA is a guideline that originated in 1987, when it was discovered that 
there was a wide range in quality and quantity of items being reported in research 
reviews. In order to be able to justify further research or clinical recommendations, 
standardizations in reporting were necessary. Using the PRISMA guidelines, current 
literature was systematically searched to select randomized controlled trials in a 
consistent, repeatable way. Data from the studies selected was collected, analyzed, 
evaluated, and reported in the same manner (Moher, Liberati, Tetzlaff, & Altman, 2009). 
The following sections describe these steps in further detail. 
Literature Search and Selection. 
 For this review, the following search terms were used: “ERAS,” “enhanced 
recovery,” “fast-track surgery,” “fast-track rehabilitation,” and “cholecystectomy.” These 
terms were entered into the Cochrane database, the Cumulative Index of Nursing and 
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Allied Health Literature (CINAHL), CINAHL Plus with Full Text, PubMed, PubMed 
Health, and MEDLINE.  
Inclusion Criteria.  
Inclusion criteria limited results to: 
a) randomized controlled trials,  
b) elective laparoscopic cholecystectomies 
c) ASA status I-II 
d) articles written in English, and  
e) articles from 2014-present. 
Exclusion Criteria. 
Studies were excluded if they:  
a) did not pertain only to adults, 18-65, or  
b) involved the treatment of cancer. 
The American Board of Surgery (2017) defines cholecystectomy surgery as a procedure 
to remove the gallbladder. The surgery can be performed open, or under laparoscopy, 
with video assistance. In the following section, methods for data collection, evaluation 
and analysis will be discussed.  
Data Collection and Evaluation. 
 Upon selection of studies to be included, data was extracted for critical appraisal 
in data tables (see Appendices C and D). Information extracted from each study included 
the study’s purpose, design, population, methods, outcomes studied, and results. The 
studies were evaluated for quality and strength of their evidence and was a factor when 
comparing data and drawing conclusions. The Critical Appraisal Skills Program (CASP) 
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was utilized in doing so (see Appendix E). CASP checklists were designed based on the 
type of research being conducted, by a group of experts over decades, in order to aid 
researchers in consistently evaluating validity, results, and clinical relevance (Critical 
Appraisal Skills Programme, 2018).  
Data Analysis. 
 Following along the PRISMA checklist, narrative form, as well as cross-analysis 
charts, were used to analyze and synthesize data. The cross-study analysis compared 
outcomes and results across studies, and can be found in Appendix F. Primary outcomes 
compared in this review include recovery time and length of stay. Secondary outcomes 
that may have affected the primary outcomes were also compared and include, but are not 
limited to, extubation time, pain scores, complication rates, and medication consumption. 
Conclusions are drawn and discussed in an integrative summation of the data. 
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Results 
 After completing the literature search, 27 articles were screened, using inclusion 
and exclusion criteria. Five articles remained. Upon further assessment, one article had 
not published final results, and was therefore excluded. The remaining four articles will 
each be discussed individually in the following pages, while summaries of their content 
can be found in appendices C through F. A visual representation of the selection process 
can be seen below in Figure B-1 of Appendix B. 
 The first study, a prospective randomized controlled trial performed by Çaparlar 
et al. (2017) compared anesthesia maintained with Sevoflurane, an anesthetic gas, to total 
intravenous anesthesia (TIVA), using Propofol and Remifentanil infusions for patients 
undergoing laparoscopic cholecystectomies. Eighty participants were computer-
randomized into two groups, the Sevoflurane group and the TIVA group. All participants 
received the same pre-operative, intra-operative, and post-operative care, as seen in the 
methods section of Table C-1, of Appendix C. The outcomes examined include 
extubation time, time from discontinuation of anesthesia to discharge, time to fast-track 
eligibility, discharge time, and complication rates, all of which can affect the primary 
outcomes examined in this review. Results are summarized in Table D-1 (see Appendix 
D). Researchers found a statistically significant difference in extubation time, time to 
fast-track eligibility, number of fast-tracked patients, and discharge times between groups 
(Çaparlar et al., 2017). Extubation time took an average of eight minutes for the 
Sevoflurane group and an average of seven minutes for the TIVA group (p = .034). Fast-
track eligibility was reached in an average of 11.5 minutes for the Sevoflurane group and 
8.5 minutes, average, in the TIVA group (p = .010). There were 23 patients in the 
Sevoflurane group and 32 in the TIVA group that were eligible for fast-track discharge (p 
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= .032). Discharge times for fast-tracked patients averaged 13 minutes for the 
Sevoflurane group and 10 minutes for the TIVA group (p = 0.032) (Çaparlar et al., 2017).  
 Utilizing the CASP tool, this article was appraised for validity, sound research, 
and clinical relevancy (see Table E-1, in Appendix E). Specific methods were followed 
so that all patients were treated as similarly as possible, apart from the treatment itself. 
Patients were blinded to treatment, but due to the nature of anesthesia gas versus 
intravenous infusions, providers were not blinded to the treatment, which could be a 
possible source of bias. After participants were randomized into their two groups, 
demographic data such as gender, age, weight, and ASA physical status were compared 
and found to have no statistical difference, minimizing population bias. To detect 
significance with an 80% power, 36 patients per group were required. Using 40 patients 
per study group, a 95% confidence interval was established when finding significant 
difference in the outcomes studied between groups. Limitations included the lack of 
blinding to health-workers and study-personnel, as well as not measuring a true effect 
size for comparison. Additionally, this study could have considered temperature 
maintenance as a variable to assess. Many ERAS protocols currently published include a 
component on patient warming, as it can affect discharge times (Fearon et al., 2005). In 
spite of these few limitations, this study was valid, minimized bias, and resulted in 
evidence that is clinically relevant. 
 Fanelli et al. (2014) conducted a prospective, randomized, double-blind placebo-
controlled trial to evaluate whether oral morphine administered pre-operatively would 
improve pain control after laparoscopic cholecystectomies, ultimately leading to faster 
discharge times. Forty-one participants were randomized into two groups, group 
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oramorph and group placebo. All participants received the same pre-operative, intra-
operative, and post-operative care, as seen in the methods section of Table C-2, of 
Appendix C. The outcomes examined that pertain to the outcomes of this review include 
time to first breathing, eye-opening, extubation, and awakening, as well as tramadol 
consumption, pain scores, postoperative nausea and/or vomiting (PONV), and anxiety. 
Results are summarized in Table D-2, found in Appendix D.  No statistical significance 
was found between groups on any parameter other than pain scores with movement, 
during the first three hours. On this outcome, patients who had received oral morphine 
reported a pain score on average of 3.23/10, compared to an average pain score of 
4.13/10 in patients who had received the placebo (p =.016) (Fanelli et al., 2014). 
 The CASP tool was used to appraise this study (see Table E-2 of Appendix E). Of 
the 41 patients who began this trial, 36 completed it. Dropouts were accounted for, but 
not well explained, leading to a potential source of bias. The two groups were well 
matched on baseline characteristics, however, and were treated equally throughout the 
perioperative period. While some efforts were taken to minimize bias, others were 
overlooked. The minimum number of participants required to have an 80% power of 
detecting significance was 18 per treatment group. This is a significant limitation of the 
study, as one group had 19 patients in the end, while the other had only 17. The treatment 
effect was not calculated for comparison, but knowing at least 18 patients per group was 
required, this study should have recruited a larger number of participants to compensate 
for dropouts, in order to have enough power to find significance. Overall, this study was 
well conducted and would have relevant results, apart from the lack of power to find 
significance. 
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 In a double blind, randomized, controlled trial by Moro et al. (2017), investigators 
administered Ketamine to evaluate its effect on recovery times for patients undergoing 
laparoscopic cholecystectomies. One hundred thirty-five patients were computer-
randomized into three groups to compare two concentrations of ketamine against saline. 
All participants received the same pre-operative, intra-operative, and post-operative care, 
as seen in the methods section of Table C-3, of Appendix C. Outcomes studied include 
quality of recovery (QoR-40) scores, time to eye-opening, pain scores, PONV, and post-
anesthesia care unit (PACU) time. Results are summarized in Table D-3 (see Appendix 
D), however, no significant difference was found between groups on any parameter 
(Moro et al., 2017). 
 Using the CASP tool to appraise this study (see Table E-3 in Appendix E), it was 
found that this study addressed a clearly focused issue. Additionally, researchers 
minimized study biases by randomizing assignment and blinding all participants and 
providers. There were no differences found between groups on baseline characteristics, 
and all patients that entered this study were accounted for at its end. In spite of using 
more than the required 30 participants per group to have a 90% power of finding 
significance, no significance was found. A limitation of this study would be that they did 
not consider the effects of timing on the administration of Ketamine. They administered 
the drug at one set time point, and it was found to be ineffective, both in reducing post-
operative pain and in reducing the amount of morphine consumed. Considering the study 
methods appear valid, the results are still relevant in that they found no significant 
difference between any of the groups on the outcomes studied. 
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 Finally, Mousa, Mowafi, Al-Metwalli, Al-Ghamdi, and Al-Gameel (2015), 
conducted a double-blind, randomized controlled study to determine if mannitol infusions 
before the induction of anesthesia would enhance recovery after surgery in patients 
undergoing laparoscopic cholecystectomies. Forty patients were computer-randomized 
into two groups, group mannitol and group control. All participants received the same 
pre-operative, intra-operative, and post-operative care (see Appendix C, Table C-4). The 
outcomes examined include cerebral oxygen saturation, time to extubation, 
alertness/sedation scale scores, and mini-mental state examination (MMSE) scores. 
Results are summarized in Table D-4 of Appendix D. A significant difference was found 
between groups on cerebral oxygen saturation, time to extubation, and the 
alertness/sedation scale scores. On these parameters, the mannitol group was found to 
have a higher oxygen saturation 30 minutes after extubation, with a mean of 65, 
compared to 53 (p < .05). The mannitol group had a shorter extubation time, averaging 
6.5 minutes compared to 9 (p < .001). Higher alertness/sedation scale scores at 10 
minutes post-extubation were found in the mannitol group, with a median score of 4, 
compared to 2 (p = .007). There was no difference found in MMSE scores (Mousa et al., 
2015). 
 Again utilizing the CASP tool, this article was appraised for validity and 
relevancy (see Appendix E, Table E-4). This trial addressed a clear issue and minimized 
bias by randomizing participants into groups and blinding both participants and providers 
to the assignment of groups. In order to have 90% power in detecting significance, 16 
patients per group were required. This study recruited enough participants to have 20 in 
each group, so there was enough for dropouts, withdrawals, etc. There was no difference 
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found between groups on baseline characteristics. A limitation of this study is that they 
did not consider pain as a factor. Cerebral oxygen consumption would be affected by how 
much pain a patient is experiencing, and is therefore a relevant variable to study. 
Additionally, the researchers could have also assessed length of stay, not just recovery 
time, to further assess Mannitol’s effectiveness. Overall, this study offers valid results 
that are relevant and have minimal risks, compared to the benefits studied. 
 A cross-study analysis was performed, in order to compare similarities and 
differences across studies, and can be found in Appendix F. The outcomes compared 
across studies were recovery time and length of stay. For the first study, Çaparlar et al. 
(2017) found that the TIVA group met fast-track eligibility faster and had shorter 
extubation times, both contributing to faster recovery times. Additionally, the TIVA 
group not only had more patients qualify for fast-track discharge, but were also 
discharged faster that the Sevoflurane group, effectively decreasing length of stay. In the 
second study, Fanelli et al. (2014) found that the morphine group reported lower pain 
scores in the first three hours postoperatively, which would contribute to a faster recovery 
time. No other differences were found between groups, so length of stay would also be 
similar between groups. The third study by Moro et al. (2017) found that Ketamine given 
just before incision had no effect on the parameters studied, and therefore did not 
decrease recovery time or length of stay. Finally, Mousa et al. (2015) found that Mannitol 
led to shorter extubation time as well as a decreased recovery time overall. Length of stay 
was not measured, but a shorter recovery time would lead to a shorter length of stay. 
Taken together, the cross-study analysis shows that oral morphine may decrease pain 
immediately after surgery, but has no effect on length of stay, while Ketamine has no 
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effect on either outcome. However, it was shown that using either Mannitol or a TIVA 
will not only shorten recovery time, but also lead to decreased lengths of stay. 
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Summary and Conclusions 
The surgical stress response can have a major impact on the body, leading to 
prolonged recovery periods and increased hospital lengths of stay. Mitigating that 
response by implementing evidence-based practices, not only helps the patient recover 
faster, but also allows for prompter hospital discharges. Consequentially, the financial 
burden on both the patient and the healthcare system is lessened. Laparoscopic 
cholecystectomies are a noteworthy procedure to focus inquiry on regarding enhanced 
recovery implementations, as they are a common same-day surgery, with little variation. 
This review was conducted in order to answer the question, which perioperative 
ERAS techniques are most effective in decreasing recovery time and length of stay for 
adults, aged 18-65, undergoing cholecystectomy surgery? Following PRISMA guidelines 
to conduct a systematic search and review, four randomized controlled trials were 
selected for inclusion. Upon data extraction and evaluation, results were compared across 
studies to evaluate the above research question and draw conclusions.  
The cross-study analysis found that TIVA and mannitol can both decrease 
recovery time and length of stay, while oral morphine and ketamine were both found to 
have no effect on either outcome. Previous research comparing TIVA to gas anesthesia 
had conflicting results. For example, studies done by Robinson, Uhrich, and Ebert (1999) 
and Gupta et al. (2004) both compared TIVA to gas anesthesia and found the patients 
receiving gas woke faster. Conflictingly, studies by Juckenhöfel, Feisel, Shcmitt, and 
Biedler (1999) as well as Larsen, Seitz, and Larsen (2000) also compared TIVA to gas 
anesthesia and found that patients receiving TIVA woke faster. In this current systematic 
review, it was noted that the study by Çaparlar et al. (2016) demonstrated faster recovery 
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times with TIVA. However, the authors emphasized that these results were specific to a 
combination of propofol and a fast-acting opioid, such as remifentanil.  
Enhanced recovery after surgery encompasses the use of treatments to increase 
oxygen flow to cerebral tissue, which is imperative in improving recovery from surgery. 
Mousa et al. (2015) confirmed previous findings that the induction of general anesthesia 
increases cerebral oxygen saturation, while insufflating the abdomen for laparoscopy 
decreases it. In their study, Mousa et al. also found that low-dose mannitol can effectively 
mitigate the decrease in cerebral oxygenation associated with insufflation when given 
preoperatively. Patients that received mannitol maintained their cerebral oxygen 
saturation, even during insufflation, leading to shorter extubation times and faster 
recovery. 
Post-operative pain control is also key to improved recovery and decreased 
lengths of stay. Interestingly, the results of this review found that neither morphine nor 
ketamine improved recovery or decreased the length of stay. Fanelli et al. (2014) 
demonstrated no statistical difference between the use of morphine compared to placebo 
on recovery time or length of stay. A few non-significant, yet clinically notable 
differences were observed, however. Patients in the placebo group had higher pain scores 
post-operatively, a higher rate of tramadol consumption, and an increased number of 
patients required further supplemental medications. One possible rationale for why this 
study did not have significant results could be that they under-estimated their power 
calculation. Another is that a multi-modal pain regimen was included as part of the 
protocol, which could have masked the true extent to which morphine decreased pain 
(Fanelli et al., 2014). Moro et al. (2017) attempted to refute previous studies and show 
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that ketamine was effective at reducing postoperative pain. They found, however, that 
when used as part of a multimodal pain regimen, ketamine did not reduce post-operative 
pain scores. Lack of significant findings in this study could be due to multiple factors. 
One possible factor is that the effects of ketamine are relatively short-lived, so perhaps an 
infusion would be more effective. Alternatively, a larger dose may be required to see the 
desired effects. Similar to the Fanelli et al. study, ketamine was administered as part of a 
multimodal regimen, which may have masked some of the effects of ketamine (Moro et 
al., 2017). 
In conclusion, the findings of this systematic review determined that utilizing 
TIVA (with propofol and remifentanil) and/or including a 20% mannitol infusion pre-
induction are two ERAS techniques that may lead to improved recovery times and shorter 
lengths of stay for patients undergoing laparoscopic cholecystectomy surgeries. 
Additionally, it was found that although morphine and ketamine may be effective in 
reducing pain in general, their results were not found to be significant in the studies 
reviewed in this project. 
Box 2. Study Recommendations 
 
 
To improve recovery time and decrease length of stay, the following are recommendations 
to consider for the patient undergoing a laparoscopic cholecystectomy: 
 
• Total IV anesthesia (Remifentanil and Propofol infusions) 
• Pre-induction 20% mannitol infusion 
 
These recommendations are in addition to other evidence-based ERAS techniques and 
protocols 
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Limitations 
In order to develop ERAS protocols that are effective at decreasing the costs 
associated with prolonged hospital stays after surgery, all components of a patient’s 
perioperative care should be assessed, not just their surgical care. A limitation of this 
research is that researchers did not assess the other components of their ERAS protocols 
or otherwise speak to their validity or reliability in order to ensure effectiveness. Another 
limitation is that only four randomized controlled trials met inclusion and exclusion 
criteria at the time of this review. Repeating this search in a few years will likely yield 
more results that will result in a more robust review. Finally, the results were limited to 
laparoscopic cholecystectomies, as these procedures are less invasive and offer faster 
recovery times than an open procedure, but expanding the search to include 
cholecystectomy surgeries in general would results in a more robust review, while still 
being specific enough to have meaning and relevance in current literature.  
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Recommendations and Implications for Advanced Nursing Practice 
 There are many health care providers involved in a patient’s care from the 
moment they step into the hospital, until they are wheeled out at discharge. Enhanced 
recovery protocols involve many of these providers, in order to provide the most efficient 
patient-focused care. Anesthesia providers have a unique role in implementing ERAS 
protocols, as some of the most efficacious ways to mitigate the stress response occur at 
the point the stress occurs, during surgery itself. Nurse anesthetists are especially critical, 
as they are constantly with a patient, from the moment they leave the pre-operative area, 
until they safely arrive in recovery.  
 The Neuman Systems Model is a useful tool that can guide the advanced nurse 
practitioner in the application of this study’s data. This model is useful in determining 
best practices, because it encourages the provider to look at the patient holistically to 
determine which environmental stressors will be a factor and how to best mitigate them. 
Upon identifying such stressors, the advanced practitioner can then better identify the 
appropriate interventions to strengthen the patient’s lines of defense and resistance, 
therefore reducing the patient’s specific stress-related response. In other words, these 
study recommendations should not be applied blindly to every patient. Accurate 
assessment, knowledge, and the use of critical judgment will guide the advanced practice 
nurse to implement these recommendations appropriately. Providers using these 
interventions should know the dosage, mechanism of action, side effect profiles, and 
contraindications for any medications used, and should be knowledgeable about the stress 
response itself and how each intervention within a given protocol further builds up a 
patient’s line of defense.  
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 The implications of these results extend beyond the providers implementing them. 
By implementing research-based ERAS protocols and their various components, nurse 
anesthetists are providing safer care and advancing the field of anesthesia as well as 
strengthening the professionalism of advanced practice nurses. Advanced practice nurses 
are also leaders in their field, and as such, should not only utilize and judiciously 
implement research-based guidelines, but should also share findings with peers. It is 
through this collective sharing of knowledge that the field of health care can advance and 
allow new and better ways of caring to emerge.  
Evidence-based research is constantly evolving. There is always room for more 
research to improve methods for providing patient care. To continue research in this area, 
other investigators may look at the many other components of ERAS when developing a 
protocol for this particular surgical population. The techniques investigated in the 
laparoscopic studies reviewed in this study may also be generalized to surgeries other 
than laparoscopic cholecystectomies. Additionally, investigations into other surgical 
populations with adjusted protocols, such as pediatric or geriatric populations would be 
beneficial. As surgeries continue to evolve and advance, so will the peri-operative care 
the surgical team provides. 
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Appendix A- Betty Neuman Systems Model 
Table A-1. Major concepts in the Neuman Systems Model 
Concept Definition 
 
Basic Structure “The basic structure or central core consists of common client 
survival factors related to system variables as well as unique 
individual characteristics. It represents the basic system energy 
resources.” 
 
Boundary 
Lines 
“The flexible line of defense is the outer boundary of the client 
system. All relevant variables must be taken into account, as the 
whole is greater than the sum of the parts; a change in one part 
affects all other system parts.” 
 
Client/client 
system 
“A total system in interaction with the internal and external 
environment. A composite of variables (physiological, 
psychological, sociocultural, developmental, and spiritual), each of 
which is a subpart of all parts, forms the whole of the client. The 
client as a system is composed of a core or basic structure of 
survival factors and surrounding protective concentric rings. The 
concentric rings are composed of similar factors, yet serve varied 
and different purposes in retention, attainment, or maintenance of 
system stability and integrity or a combination of these. The client is 
considered an open system in total interface and exchange of matter 
and information with the environment. The client is viewed as a 
system, and the term can be used interchangeably with the 
client/client system; that is, individual, family, community, and 
social issues are considered a system with boundaries and 
identifiable interacting parts.”  
 
Content “The five variables of person in interaction with the internal and 
external environment comprise the whole client system.” 
 
Degree of 
reaction 
“The degree of reaction is the degree of system instability resulting 
from stressor invasion of the normal line of defense.” 
 
Environment “The environment consists of both internal and external forces 
surrounding the client, influencing and being influenced by the 
client, at any point in time, as an open system. The created 
environment is an unconsciously developed protective environment 
that binds system energy and encompasses both the internal and 
external client environments; it acts as a perceptual safety 
mechanism to maintain system stability.” 
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Feedback “The process within which matter, energy, and information, as a 
system output, provide feedback for corrective action to change, 
enhance, or stabilize the system.” 
 
Flexible line of 
defense 
“The flexible line of defense is a protective, accordionlike 
mechanism that surrounds and protects the normal line of defense 
from invasion by stressors. The greater the expansiveness of this 
line from the normal line of defense, the greater the degree of 
protectiveness. Examples are situational, such as recently altered 
sleep patterns or immune functions that could threaten system 
stability and lessen the potential for survival and optimal wellness.” 
 
Health “A continuum of wellness to illness, dynamic in nature, that is 
constantly subject to change. Optimal wellness or stability indicated 
that total system needs are being met. A reduced state of wellness is 
the result of unmet systemic needs. The client is in a dynamic state 
of either wellness or illness, in varying degrees, at any given point 
in time. Health is related to available energy to support the system.” 
 
Input/output “The matter, energy, and information exchanged between client and 
environment that is entering or leaving the system at any point.” 
 
Lines of 
resistance 
“Protection factors activated when stressors have penetrated the 
normal line of defense, causing the reaction symptomatology. The 
resistance lines ideally protect the basic structure and facilitate 
reconstitution toward wellness during and following treatment, as 
the stressor reaction is decreased and client resistance is increased. 
All lines of defense and resistance are considered to contain both 
internal and external resources.” 
 
Negentropy “A process of energy conservation that increases organization and 
complexity, moving the system toward stability or a higher degree 
of wellness. Stability and degree of wellness have a direct 
relationship.” 
 
Normal line of 
defense 
“An adaptation level of health developed over time and considered 
normal for a particular client or system; it becomes a standard for 
wellness deviance determination.” 
 
Nursing “A unique profession concerned with all variables affecting clients 
in their environment. Nursing is preventative intervention.” 
 
Open system “A system in which there is a continuous flow of input and process, 
output and feedback. It is a system or organized complexity, where 
all elements are in interaction. Stress and reaction to stress are basic 
components.” 
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Prevention as 
intervention 
“Intervention typology or modes for nursing action and 
determinants for entry of both client and caregiver into the health 
care system. Primary prevention: before a reaction to stressors 
occurs. Secondary prevention: Treatment of symptoms following a 
reaction to stressors. Tertiary prevention: maintenance of optimal 
wellness following treatment.” 
 
Process/ 
function 
“The function or process of the system is the exchange of matter, 
energy, and information with the environment and the interaction of 
the parts and subparts of the client system. A living system tents to 
move toward wholeness, stability, wellness, and negentropy based 
on effective use of available energy sources.” 
 
Reconstitution “Represents the return and maintenance of system stability, 
following treatment of a stressor reaction, which may result in a 
higher or lower level of wellness than previously. It represents 
successful mobilization of energy resources.” 
 
Stability “A desired state of balance or harmony while system energy 
exchanges take place without disrupting the character of the system. 
The dynamic nature of stability is seen as the client, as a system, 
adequately copes with stressors to retain, attain, or maintain optimal 
health and integrity.” 
 
Stressors “Environmental factors that are intra, inter, and extrapersonal in 
nature and have the potential for disrupting system stability by 
penetrating the system lines of defense and resistance. Their 
outcome may be either positive or negative; client perception and 
coping ability are major considerations for caregivers and clients.” 
 
Wellness/illness “Wellness is a stable condition in which system subparts are in 
harmony with the whole system. Wholeness is based on the 
interrelationships of variables, which determine the amount of 
resistance to stressors. Illness is on the opposite continuum from 
wellness and represents instability and energy depletion among the 
system parts or subparts affecting the whole.” 
 
Wholistic “A system is considered wholistic when its parts or subparts can be 
organized into an interrelating whole. The ideal is one of keeping 
parts stable within their intimate relationships with the whole 
system; that is, individuals are viewed as wholes whose component 
parts are in dynamic interdependent interaction while adjusting to 
environmental stressors.” 
 
 (Neuman & Fawcett, 2002, pg. 322-324) 
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Appendix B- PRISMA: Further Information 
 
Figure B-1. 
 
  
 PRISMA 2009 Flow Diagram 
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Table B-1.  PRISMA Checklist 
Section/topic  # Checklist item  Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.   
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: background; objectives; data sources; study 
eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; 
limitations; conclusions and implications of key findings; systematic review registration number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.   
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, 
interventions, comparisons, outcomes, and study design (PICOS).  
 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if 
available, provide registration information including registration number.  
 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors 
to identify additional studies) in the search and date last searched.  
 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it 
could be repeated.  
 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, 
if applicable, included in the meta-analysis).  
 
Data collection 
process  
10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and 
any processes for obtaining and confirming data from investigators.  
 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made.  
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Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of 
whether this was done at the study or outcome level), and how this information is to be used in any 
data synthesis.  
 
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, difference in means).   
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures 
of consistency (e.g., I2) for each meta-analysis.  
 
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, 
selective reporting within studies).  
 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified.  
 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons 
for exclusions at each stage, ideally with a flow diagram.  
 
Study 
characteristics  
18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, 
follow-up period) and provide the citations.  
 
Risk of bias within 
studies  
19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 
12).  
 
Results of 
individual studies  
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data 
for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of 
consistency.  
 
Risk of bias across 
studies  
22 Present results of any assessment of risk of bias across studies (see Item 15).   
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression 
[see Item 16]).  
 
DISCUSSION   
Summary of 
evidence  
24 Summarize the main findings including the strength of evidence for each main outcome; consider 
their relevance to key groups (e.g., healthcare providers, users, and policy makers).  
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Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., 
incomplete retrieval of identified research, reporting bias).  
 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for 
future research.  
 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of 
funders for the systematic review.  
 
(Moher et al., 2009) 
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Appendix C- Descriptive Data Tables 
 
Table C-1. 
 
TITLE Fast-track anesthesia in patients undergoing outpatient laparoscopic cholecystectomy: Comparison of sevoflurane with total intravenous anesthesia 
PURPOSE “To compare sevoflurane anesthesia and remifentanil-propofol-based TIVA with regard to fast-track eligibility in patients undergoing outpatient laparoscopic cholecystectomy.”                                                            (p. 26) 
DESIGN Prospective, randomized controlled trial 
 
SAMPLE 
 
- Inclusion criteria: Adult, ASA* status I-III, undergoing outpatient laparoscopic cholecystectomy, through the 
department of Anesthesiology at either Yildirim Beyazit Training and Research Hospital or 29 Mayis Hospital 
- Exclusion criteria: >40% above normal body weight, pregnant, history of intra-abdominal surgery, history of 
smoking or drug abuse, communication problems 
 
- Resulted with 80 Individuals, aged 31-79 years old, randomly assigned into one of two study groups: group 
sevoflurane or group TIVA** 
 
METHODS 
 
All participants: 6-hour fast pre-op; anesthesia induced with 2 mg/kg Propofol, 2 µg/kg Fentanyl, and 0.6 mg/kg 
Rocuronium; endotracheal tube placed 3 minutes after induction; 50% air mix used for maintenance; 10mg 
metoclopramide, 30 mg ketorolac, and 0.5 mg/kg meperidine were given; a total of 20ml local anesthetic 
mixture (containing 100mg lidocaine and 75mg bupivacaine) injected between trocar sites; reversal of paralysis 
with 50 µg/kg neostigmine and 20 µg/kg atropine; extubation upon spontaneous breathing and consciousness; 
 
- Group Sevoflurane: Anesthesia maintained with sevoflurane, titrated between 2-2.5% to maintain heart rate 
and MAP*** within 20% of baseline levels 
 
- Group TIVA: Anesthesia maintained with remifentanil-propofol drip, titrated (remifentanil: 0.1-0.2 µg/kg/min; 
propofol: 80-95 µg/kg/min) to maintain heart rate and MAP*** within 20% of baseline levels with 50% air 
Çaparlar, C. Ö, Özhan, M. Ö, Süzer, M. A., Yazicioğlu, D., Eşkin, M. B., Şenkal, S., . . . Çekmen, N. (2017). Fast-track 
anesthesia in patients undergoing outpatient laparoscopic cholecystectomy: Comparison of sevoflurane with total intravenous 
anesthesia. Journal of Clinical Anesthesia, 37, 25-30. doi:10.1016/j.jclinane.2016.10.036 
*ASA: American Society of Anesthesiologists **TIVA: Total Intravenous Anesthesia ***MAP: Mean arterial pressure 
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Table C-2. 
 
TITLE 
Pilot double-blinded study to assess efficacy and tolerability of morphine sulphate oral solution (Oramorph®) given 
preoperatively as add-on therapy within a multimodal postoperative pain approach in patients undergoing 
laparoscopic cholecystectomy 
PURPOSE 
“… to evaluate if the preoperative administration of oral morphine sulphate 30 mg (Oramorph®), within a 
multimodal strategy for pain therapy, could improve postoperative pain control after laparoscopic cholecystectomy, 
reducing theuse of opioids after surgery and leading to faster PACU discharge times” (p. 67) 
DESIGN Prospective, randomized, double-blind, placebo-controlled trial 
 
SAMPLE 
 
- Inclusion criteria: 18-65 years old, ASA* status I-III, undergoing elective laparoscopic cholecystectomy at the 
Istituti Ospitalieri di Cremona, in Cremona, Italy 
-Exclusion criteria: frequent use of opioids, analgesics taken during 12 hours preceding surgery, serum creatinine 
≥1.4 mg/dL, dysmetabolic or hepatic failure, contraindications to any study medication, history of alcoholism or drug 
abuse, pregnant/breastfeeding women, and a baseline MMSE** score <24 
- Resulted in 41 participants, randomized into two groups 
METHODS 
 
All participants: IV crystalloids started and maintained for 20 minutes prior to induction of anesthesia at 7 ml/kg/h. 
IVF continued at 2 ml/kg/h basal rate, with changes based on patient’s hemodynamics. Pre-oxygenation for 3 
minutes, followed by induction of anesthesia with remifentanil 0.5 µg/kg/min until patients felt dazed. 20mg IV 
Lidocaine 1%, Ketamine 0.2mg/kg, and propofol 2 mg/kg were given, followed by Cisatracurium 0.15-.2 mg/kg. 
Ventilation was titrated to maintain 10ml/kg tidal volume, 12 breaths/min, and ETCO2*** 30-35 mmHg. Surgery 
proceeded after BIS**** value reached 40-60, and BP and HR within 20% of baseline. Insufflation pressures kept 
between 8-12 mmHg, and room temperature kept at 21°C with 40% humidity. Oral gastric tube placed 90 minutes 
after treatment administration. 30mg Ketorolac given at the extraction of the gallbladder. TIVA infusions were 
stopped after skin closure and 0.01 mg/kg Atropine and 0.02 mg/kg Neostigmine were given. Gastric tube removed 
prior to patient wakening. Extubation after criteria met. PONV prophylaxis based on risk assessment- low risk: 5mg 
tropisetron, high risk: add 4mg dexamethasone. Postoperative PCA pump for first 24 hours.  
Treatment Group Only: 30 mg Oramorph® or placebo, taken orally, 60 minutes prior to induction of anesthesia 
Fanelli, A., Ghisi, D., Pergolotti, B., Martinotti, M., Fanelli, G., & Danelli, D. (2014). Pilot double-blinded study to assess efficacy and tolerability of 
morphine sulphate oral solution (Oramorph®) given preoperaticely as add-on therapy within a multimodal postoperative pain approach in patients 
undergoing laparoscopic cholecystectomy. Minerva Anestesiologica, 80(1), 66-75. 
* ASA: American Society of Anesthesiologists **MMSE: Mini-mental state examination ***ETCO2: End Tidal CO2 ***BIS: Bispectral Index 
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Table C-3. 
 
TITLE Ketamine does not enhance the quality of recovery following laparoscopic cholecystectomy: a randomized control trial 
AIM/PURPOSE 
“… to assess the effect of low-dose ketamine, when used as part of a multimodal analgesic regimen, on the 
quality of recovery of patients undergoing laparoscopic cholecystectomy under remifentanil-propofol based 
anesthesia”                                                                                                                                                 (pg. 741) 
DESIGN Randomized, controlled, double-blinded trial 
 
SAMPLE 
 
Inclusion criteria: Patients undergoing laparoscopic cholecystectomy at Santa Lucinda Hospital, aged 18-65, 
ASA I-II; 
Exclusion criteria: refusal, altered level of consciousness, history of drug or alcohol abuse, contraindication to 
ketamine or any other medication used in this study, BMI ≥ 40 
 
- Resulted in 135 patients, randomized into 3 groups 
 
 
 
 
METHODS 
 
 
 
- All care providers, patients, and researchers were blinded to group assignments. An independent 
anesthesiologist drew up the appropriate doses into identical 5ml syringes. 
 
All participants were induced with 0.06 mg/kg IV midazolam, 30mg 1% lidocaine, 0.5 µg/kg/min remifentanil 
for three minutes, 2.0 mg/kg propofol and 0.6 mg/kg rocuronium. Maintenance anesthesia was achieved with 
0.3 µg/kg/min and 4-6 mg/kg/hr propofol; 8mg dexamethasone and 100mg ketoprofen were given at the onset 
of surgery. Ephedrine and atropine were given as needed, and normal saline was used for maintenance fluids. 
15 minutes prior to the end of surgery, all participants received 30mg dimenhydrinate, 1g dipyrone, and 0.1 
mg/kg morphine 
 
Study participants received 5ml of saline, 0.2 mg/kg ketamine in saline, or 0.4 mg/kg ketamine in saline, 
immediately following induction 
Moro, E. T., I. M. P. S. S. Feitosa, Oliveira, R. G., Saraiva, G. F., Rosalino, R., Marossi, V. P., . . . Navarro, L. H. (2017). 
Ketamine does not enhance the quality of recovery following laparoscopic cholecystectomy: A randomized controlled trial. Acta 
Anaesthesiologica Scandinavica, 61(7), 740-748. doi:10.1111/aas.12919 
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Table C-4. 
 
TITLE Preoperative mannitol infusion improves perioperative oxygen saturation and enhances postoperative recovery after laparosopic cholecystectomy 
AIM/PURPOSE “The aim of this study was to test, whether mannitol infusion before anesthetic induction for laparoscopic surgery would improve rS02 and enhance recovery.”                                                                             (pg. 1200) 
DESIGN Double-blind, randomized controlled study 
 
SAMPLE 
 
Inclusion criteria: Willing patients undergoing laparoscopic cholecystectomy at Dammam Hospital, between 
December 2013-June 2014, ASA* I-II, ages 25-50 years old, BMI: 22-34 kg/m^2 
Exclusion criteria: significant obstructive or restrictive pulmonary disease, significant cardiac dysfunction 
 
- Resulted in 40 patients, randomized into 2 groups 
 
METHODS 
 
All participants: Standardized anesthetic regimen used, including- induction with 2 mg/kg propofol and 2 
µg/kg fentanyl, followed by 0.6 mg/kg rocuronium; anesthesia maintained with sevoflurane, titrated according 
to BIS monitoring; Pain and hemodynamic changes were treated with standard doses of appropriate 
medications; Vital signs were maintained within 20% of baseline and adequate temperature was maintained; 
Standard reversal doses of neostigmine/glycopyrrolate were used; patients were extubated when criteria were 
met;  
 
Study participants: Group M received 0.5 mg/kg 20% mannitol infusion 10 minutes before the induction of 
anesthesia. Group C received the same volume in saline 
Mousa, W., Mowafi, H., Al-Metwalli, R., Al-Ghamdi, A., & Al-Gameel, H. (2015). Preoperative mannitol infusion improves 
perioperative cerebral oxygen saturation and enhances postoperative recovery after laparoscopic cholecystectomy. Saudi Medical 
Journal, 36(10), 1199-1204. doi:10.15537/smj.2015.10.1210 
* ASA: American Society of Anesthesiologists **MMSE: Mini-mental state examination 
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Appendix C: Outcome Data Collection Tables 
 
Table D-1. 
 
Outcomes Sevoflurane Group TIVA Group P-value* Significance 
Extubation time (min) t(ext)= 8 (4-12) t(ext)= 7 (4-11) .034 - Extubation time was shorter for the TIVA group 
Number of fast-tracked 
patients, n(%) 23 (57.5) 32 (82.1) .018 
- More patients qualified for fast-track 
discharge in the TIVA group 
Time from discontinuation 
of anesthesia to discharge, 
minutes: mean (range) 
Fast-tracked patients: 
13 (7-19) 
Non fast-tracked 
patients: 
26 (21-38) 
Fast-tracked patients: 
10 (5-14) 
Non fast-tracked 
patients: 
30 (24-34) 
 
.032 
 
.228 
- Fast-tracked patients were discharged 
faster in the TIVA group 
- Non fast-tracked patients saw no 
difference in discharge time between 
groups 
Time after extubation to 
fast-track eligibility* 
minutes: mean (range) 
- for fast-tracked patients ONLY 
11.5 (7-16) 8.5 (5-11) .010 - Patients met fast-track eligibility faster in the TIVA group 
Discharge time from 
PACU** (min) 
- for non-fast track patients ONLY 
14 (10-23) 15 (10-20) .852 
- No statistical difference in discharge 
time from PACU was found between 
groups 
Complication rates, n(%) 
 
HI: Hemodynamic instability 
PONV: postoperative nausea/vomiting 
- Desaturation: 5 (12.5) 
- HI: 4 (10) 
- PONV: 4 (10) 
- Pain: 4 (10) 
- Desaturation: 3 (7.7) 
- HI: 2 (5.1) 
- PONV: 0 (0) 
- Pain: 2 (5.1) 
.712 
.675 
.016 
.675  
- There was no statistical significance 
found in complication rates between the 
patients that did not meet fast-track 
criteria, except for the measure of PONV 
Çaparlar, C. Ö, Özhan, M. Ö, Süzer, M. A., Yazicioğlu, D., Eşkin, M. B., Şenkal, S., . . . Çekmen, N. (2017). Fast-track 
anesthesia in patients undergoing outpatient laparoscopic cholecystectomy: Comparison of sevoflurane with total intravenous 
anesthesia. Journal of Clinical Anesthesia, 37, 25-30. doi:10.1016/j.jclinane.2016.10.036 
*p-values < .05 was considered statistically significant  **PACU: Post anesthesia care unit 
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*p-values < .05 was considered statistically significant  
 
Table D-2. 
 
Outcomes Group Oramorph® Group Placebo P-value* Significance 
Time Parameters 
Reported as: average (range) 
Time to (in mins) 
   - first breathing: 4 (0-13) 
   - eyes opening: 7 (1-18) 
   - extubation: 8 (2-18) 
   - awakening: 9 (2-19) 
Time suture-BIS>80: 3 (1-15) 
Time to (in mins) 
   - first breathing: 2 (0-7) 
   - eyes opening: 5 (0-11) 
   - extubation: 5 (1-11) 
   - awakening: 6 (1-11) 
Time suture-BIS>80: 4 (0-14) 
 
0.099 
0.252 
0.254 
0.282 
0.329 
- There was no significant difference 
between groups on any of the time 
parameters studied. 
Tramadol 
Consumption 
 
Cumulative = 24-hour total: 
mean ± SD (range)  
Required rescue dose: n(%)  
        13 (76.5)  
Cumulative dose:  
        185 ± 142 mg (0- 550mg) 
Required rescue dose: n(%)  
        18 (94.7) 
Cumulative dose:  
       263 ± 199mg (100-700mg) 
 
0.0668 
 
0.0563 
- While a clinical difference was 
noticed, there was no statistically 
significant difference found between 
groups in tramadol consumption 
Pain Scores 
Measured during first 3 
hours after awakening 
(mean ± SD) 
- Mean pain at rest: 
        2.57 ± 0.26 
- Mean pain with movement: 
        3.23 ± 0.28 
- Mean pain at rest: 
        3.11 ± 0.25 
- Mean pain with movement: 
        4.13 ± 0.26 
 
0.162 
 
0.035 
- There was a statistically significant 
difference between groups in pain 
scores with movement, during the 
first three hours of awakening 
PONV 
n(%) 
≥ 1 PONV episode: 9 (52.9) ≥ 1 PONV episode: 10 (52.6) 0.985 - No statistical difference in rates of PONV between groups 
Anxiety 
Measured anxiety  
state and trait 
Change in state score, at 12h:  
        -21.99 ± 5.18 
Change in state score, at 24h: 
        -29.04 ± 5.02 
Change in trait score, at 12h: 
        -8.48 ± 4.41 
Change in trait score, at 24h: 
        -6.60 ± 3.43 
Change in state score, at 12h:  
        -24.85 ± 4.90 
Change in state score, at 24h: 
        -26.86 ± 4.75 
Change in trait score, at 12h: 
        -10.18 ± 4.04 
Change in trait score, at 24h: 
        -6.60 ± 3.43 
 
0.691 
 
0.754 
 
0.784 
 
0.412 
- There was no statistical difference 
between groups on anxiety score 
changes when compared to pre-
medication scores, at both 12 and 24 
hours 
Fanelli, A., Ghisi, D., Pergolotti, B., Martinotti, M., Fanelli, G., & Danelli, D. (2014). Pilot double-blinded study to assess efficacy and tolerability of morphine 
sulphate oral solution (Oramorph®) given preoperaticely as add-on therapy within a multimodal postoperative pain approach in patients undergoing 
laparoscopic cholecystectomy. Minerva Anestesiologica, 80(1), 66-75. 
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Table D-3.  
 
Outcomes Group: Saline n= 39 
Group: K2 
n= 37 
(0.2 mg/kg Ketamine) 
Group: K4 
n= 43 
(0.4 mg/kg Ketamine) 
P-values 
(Using ANOVA, then 
Tukey’s multiple 
comparison test) 
Significance 
 
QoR-40 Score 
 
Quality of recovery questionnaire 
(mean ± SD) 
 
190 ± 10.3 191 ± 7.3 187 ± 11.5 0.54 
- No significant 
difference found between 
groups 
Time to eye opening 
 
Minutes (mean ± SD) 
15.4 ± 5.2 15.1 ± 5.1 16.0 ± 5.3 0.70 
- No significant 
difference found between 
groups 
Pain Score 
 
Numerical Rating Score  
(mean ± SD) 
3.8 ± 3.6 2.6 ± 3.2 2.8 ± 3.0 0.27 
- No significant 
difference found between 
groups 
 
PONV 
 
Incidence: n(%) 
 
12 (30.8) 11 (29.7) 17 (39.5) 0.59 
- No significant 
difference found between 
groups 
PACU time  
 
Minutes (mean ± SD) 
82.9 ± 23.9 84.5 ±16.6 86.0 ± 34.0 0.87 
- No significant 
difference found between 
groups 
Moro, E. T., I. M. P. S. S. Feitosa, Oliveira, R. G., Saraiva, G. F., Rosalino, R., Marossi, V. P., . . . Navarro, L. H. (2017). 
Ketamine does not enhance the quality of recovery following laparoscopic cholecystectomy: A randomized controlled trial. Acta 
Anaesthesiologica Scandinavica, 61(7), 740-748. doi:10.1111/aas.12919 
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Table D-4. 
 
Outcomes Group M:  Mannitol Infusion Group C: Control P-values Significance 
 
Cerebral Oxygen 
Saturation (rS02) 
 
rSO2: Mean ± 95% CI 
  
30 minutes after 
extubation: 65 ± 3 
30 minutes after 
extubation: 53 ± 3 p < 0.05 
- Significant difference in  
cerebral oxygen saturation  
between groups at T5;  
Time to extubation  
 
Minutes: average ± SD 
6.5 ± 1 9 ± 2 p < 0.001 - Significantly shorter in the  mannitol group 
Observer’s Assesment of 
Alertness/Sedation  
(OOAS) Scale 
 
median (interquartile range) 
 10 minutes after 
extubation: 4 (3-4) 
20 minutes after  
extubation:  
no difference 
10 minutes after 
extubation: 2 (2-4) 
 
p = 0.007 - Significantly higher in the mannitol group, at ten minutes 
Mini-mental State 
Examination 
(MMSE) 
 
median (interquartile range) 
10 minutes after 
extubation: 
no difference 
10 minutes after 
extubation: 
 no difference 
P > 0.05 - No difference found  between groups 
Mousa, W., Mowafi, H., Al-Metwalli, R., Al-Ghamdi, A., & Al-Gameel, H. (2015). Preoperative mannitol infusion improves 
perioperative cerebral oxygen saturation and enhances postoperative recovery after laparoscopic cholecystectomy. Saudi Medical 
Journal, 36(10), 1199-1204. doi:10.15537/smj.2015.10.1210 
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Appendix E: Critical Appraisal Skills Programme (CASP) Randomized Control Trials Checklist Tables 
Table E-1. 
 
Çaparlar, C. Ö, Özhan, M. Ö, Süzer, M. A., Yazicioğlu, D., Eşkin, M. B., Şenkal, S., . . . Çekmen, N. (2017). Fast-track 
anesthesia in patients undergoing outpatient laparoscopic cholecystectomy: Comparison of sevoflurane with total intravenous 
anesthesia. Journal of Clinical Anesthesia, 37, 25-30. doi:10.1016/j.jclinane.2016.10.036 
Question Yes Can’t Tell No Comments 
1. Did the trial address a clearly focused issue? X    
2. Was the assignment of patients to treatments 
randomized? X   Computer-randomization 
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? X    
4. Were patients, health workers and study 
personnel “blind” to treatment?   X 
Due to the nature of gas versus IV anesthetics, 
neither participants, nor healthcare workers were 
blinded to group assignment 
5. Were the groups similar at the start of the trial? X    
6. Aside from the experimental intervention, were 
the groups treated equally? X   See Appendix B-1: Methods 
7. How large was the treatment effect? Using 36+ patients in each group achieves an 80% power to detect the determined odds-ratio 
8. How precise was the estimate of ttreatment 
effect? 
95% confidence was established, but true effect size was not measured for 
comparison 
9. Can the results be applied to the local 
population, or in your context? X   
The patients are similar in baseline characteristics to 
the patients encountered in my practice; 
10. Were all clinically important outcomes 
considered?   X 
Temperature maintenance was not considered, and 
could be considered clinically relevant. 
11. Are the benefits worth the harms and costs? X   There were minimal risks. Implementation would help lower costs and increase safety and efficiency 
(Critical Appraisal Skills Programme, 2018) 
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Table E-2. 
 
Fanelli, A., Ghisi, D., Pergolotti, B., Martinotti, M., Fanelli, G., & Danelli, D. (2014). Pilot double-blinded study to assess efficacy 
and tolerability of morphine sulphate oral solution (Oramorph®) given preoperaticely as add-on therapy within a multimodal 
postoperative pain approach in patients undergoing laparoscopic cholecystectomy. Minerva Anestesiologica, 80(1), 66-75. 
Question Yes Can’t 
Tell 
No Comments 
1. Did the trial address a clearly focused issue? X    
2. Was the assignment of patients to treatments 
randomized? 
X    
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? 
X   41 patients were screened and randomized; 36 
patients were included in the final results, with the 
other 5 patients accounted for 
4. Were patients, health workers and study 
personnel “blind” to treatment? 
X   Patients, providers, and data collectors were blind to 
group assignment 
5. Were the groups similar at the start of the trial? X   When comparing groups, no significant difference 
was found between gender, race, age, weight, height, 
ASA status, and baseline MMSE and Apfel’s scores 
6. Aside from the experimental intervention, were 
the groups treated equally? 
X   See Appendix B-2: Methods 
7. How large was the treatment effect? 18 patients per treatment group was required to have an 80% power 
8. How precise was the estimate of the treatment 
effect? 
“NRS Values during the first 3 hours after awakening were lower than 
expected in both groups, which indicated that the power calculation could be 
under-dimensioned” (pg. 72) 
9. Can the results be applied to the local 
population, or in your context? 
X   The patients are similar in baseline characteristics to 
the patients encountered in my practice; 
10. Were all clinically important outcomes 
considered? 
X   Many relevant primary and secondary outcomes were 
considered 
11. Are the benefits worth the harms and costs?  X 
 
 Treatment had no discernable effect and frequency of 
adverse events was similar between groups 
(Critical Appraisal Skills Programme, 2018) 
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Table E-3. 
 
Moro, E. T., I. M. P. S. S. Feitosa, Oliveira, R. G., Saraiva, G. F., Rosalino, R., Marossi, V. P., . . . Navarro, L. H. (2017). 
Ketamine does not enhance the quality of recovery following laparoscopic cholecystectomy: A randomized controlled trial. Acta 
Anaesthesiologica Scandinavica, 61(7), 740-748. doi:10.1111/aas.12919 
Question Yes         Can’t Tell No Comments 
1. Did the trial address a clearly focused issue? X    
2. Was the assignment of patients to treatments 
randomized? X   Computer-randomized 
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? X   
135 patients were enrolled, with all exclusions and 
dropouts accounted for 
4. Were patients, health workers and study 
personnel “blind” to treatment? X   
All patients, providers, and researchers were blind to 
the treatment groups 
5. Were the groups similar at the start of the trial? X   There was no difference found between patient characteristics 
6. Aside from the experimental intervention, were 
the groups treated equally? X   See Appendix B-2: Methods 
7. How large was the treatment effect? To detect a 10-point difference in QoR-40 score, with 90% power, 30 participants per group were needed 
8. How precise was the estimate of the treatment 
effect? It was not precise, as no difference was found; 
9. Can the results be applied to the local 
population, or in your context? X   
The patients are similar in baseline characteristics to 
the patients encountered in my practice; 
10. Were all clinically important outcomes 
considered? X    
11. Are the benefits worth the harms and costs?  X  
No difference was found in outcomes between 
groups and frequency of adverse events was similar 
as well 
(Critical Appraisal Skills Programme, 2018) 
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Table E-4. 
 
Mousa, W., Mowafi, H., Al-Metwalli, R., Al-Ghamdi, A., & Al-Gameel, H. (2015). Preoperative mannitol infusion improves 
perioperative cerebral oxygen saturation and enhances postoperative recovery after laparoscopic cholecystectomy. Saudi Medical 
Journal, 36(10), 1199-1204. doi:10.15537/smj.2015.10.12105 
Question Yes Can’t Tell No Comments 
1. Did the trial address a clearly focused issue? X    
2. Was the assignment of patients to treatments 
randomized? X   Computer-randomization 
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? X    
4. Were patients, health workers and study 
personnel “blind” to treatment? X   Data collectors were blinded 
5. Were the groups similar at the start of the trial? X    
6. Aside from the experimental intervention, were 
the groups treated equally? X   See Appendix B-4: Methods 
7. How large was the treatment effect? To detect a 20% difference in cerebral oxygen saturation with 90% power, 16 patients per group are needed 
8. How precise was the estimate of the treatment 
effect? 
Significance was found, but no treatment estimate was calculated for 
comparison 9. Can the results be applied to the local 
population, or in your context? X   
Inclusion/Exclusion criteria matched, along with 
procedure and other methods 
10. Were all clinically important outcomes 
considered?   X 
Pain was not addressed. Cerebral oxygen 
consumption would be affected by how much pain a 
patient may have been in. 
11. Are the benefits worth the harms and costs? X   
In my opinion; there were minimal risks to 
receiving the study drug, and the implications 
would help decrease costs, while increasing safety 
and efficiency 
(Critical Appraisal Skills Programme, 2018) 
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Appendix F: Cross-Study Analysis 
 
Table F-1. 
 
Authors & Year Study Comparisons 
Outcome #1:  
Recovery Time 
Outcome #2:  
Length of Stay Comments 
Çaparlar, C. Ö, Özhan, M. 
Ö, Süzer, M. A., 
Yazicioğlu, D., Eşkin, M. 
B., Şenkal, S., . . . 
Çekmen, N. (2017) 
Sevoflurane vs. 
TIVA* 
- Patients met fast-track 
eligibility faster in the 
TIVA group 
- Extubation time was 
shorter for the TIVA 
group 
- More patients qualified 
for fast-track discharge in 
the TIVA group  
- fast-tracked patients 
were discharged faster 
from the TIVA group 
- TIVA was found to 
produce both faster 
recovery times, and 
shorter lengths of stays 
Fanelli, A., Ghisi, D., 
Pergolotti, B., Martinotti, 
M., Fanelli, G., & 
Danelli, D. (2014) 
Morphine vs. 
Placebo 
- The morphine group 
reported lower pain scores 
with movement in the first 
3 hours postop 
- Showed no difference 
between groups on 
PONV** score, tramadol 
consumption, anxiety, 
pain at rest, or on any 
time parameters 
- Morphine may improve 
short-term recovery 
within the first 3 hours, 
but it had no effect on 
length of stay, or any 
other parameters 
measured 
Moro, E. T., I. M. P. S. S. 
Feitosa, Oliveira, R. G., 
Saraiva, G. F., Rosalino, 
R., Marossi, V. P., . . . 
Navarro, L. H. (2017) 
Ketamine at 0.2 
mg/kg vs. 
Ketamine at 0.4 
mg/kg vs. 
Saline 
- No significant difference 
found between groups 
- No significant difference 
found between groups 
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